- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 741278 [Title] => GE leads $100-M fund for breast cancer challenge [Summary] =>GE and four venture capital firms have pledged $100 million for a six-month contest to finance ideas for improving breast cancer detection.
[DatePublished] => 2011-10-27 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 728197 [Title] => GE Healthcare to invest $1 billion in new oncology solutions [Summary] =>GE Healthcare, the health business of General Electric, announced its plans to dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its world-class technologies for the manufacture of biopharmaceuticals and for cancer research.
[DatePublished] => 2011-09-19 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Lifestyle Business [SectionUrl] => business-life [URL] => ) ) )
JOHN DINEEN
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 741278 [Title] => GE leads $100-M fund for breast cancer challenge [Summary] =>GE and four venture capital firms have pledged $100 million for a six-month contest to finance ideas for improving breast cancer detection.
[DatePublished] => 2011-10-27 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 728197 [Title] => GE Healthcare to invest $1 billion in new oncology solutions [Summary] =>GE Healthcare, the health business of General Electric, announced its plans to dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its world-class technologies for the manufacture of biopharmaceuticals and for cancer research.
[DatePublished] => 2011-09-19 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Lifestyle Business [SectionUrl] => business-life [URL] => ) ) )
abtest
EZ2 - 12 21
SUERTRES - 2 1 3
6D Lotto - 7 5 9 3 0 1
6/42 Lotto - 5 26 2 21 8 27
P19,033,913.00
6/49 Super Lotto - 32n 24 38 35 15
P62,95,035.00
- 12:00 am